What is the appropriate dose of Polymyxin B for a 2‑year‑old child weighing 30 lb (≈13.6 kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Polymyxin B Dosing for a 2-Year-Old Child Weighing 30 lb (13.6 kg)

For a 2-year-old child weighing 13.6 kg, administer polymyxin B at 15,000–25,000 units/kg/day intravenously, divided every 12 hours, which translates to 204,000–340,000 units per day (102,000–170,000 units every 12 hours). Infants with normal kidney function may receive up to 40,000 units/kg/day (544,000 units/day for this child) without adverse effects 1.

Dosing Calculation and Administration

For this 13.6 kg child:

  • Standard dose range: 15,000–25,000 units/kg/day = 204,000–340,000 units/day
  • Divided dosing: Give every 12 hours (102,000–170,000 units per dose)
  • Maximum safe dose for infants: Up to 40,000 units/kg/day = 544,000 units/day 1

Preparation: Dissolve 500,000 polymyxin B units in 300–500 mL of 5% Dextrose Injection for continuous intravenous drip 1.

Critical Dosing Considerations

Age-Specific Factors

  • This child falls into the "infants and children" category per FDA labeling, where higher doses (up to 40,000 units/kg/day) have been used safely in limited studies, particularly for serious infections like Pseudomonas aeruginosa sepsis 1
  • Doses as high as 45,000 units/kg/day have been studied in premature and newborn infants for P. aeruginosa sepsis 1

Renal Function Monitoring

  • Baseline assessment required: Polymyxin B dosing must be reduced in renal impairment 1
  • The standard dose assumes normal kidney function; any renal dysfunction necessitates downward adjustment from 15,000 units/kg 1
  • Monitor renal function closely during therapy, as nephrotoxicity is dose-limiting 2, 3

Loading Dose Consideration

While the FDA label doesn't specify a loading dose for pediatric patients 1, adult guidelines recommend loading doses of 2–2.5 mg/kg to achieve rapid therapeutic levels 4. For severe infections in this child, consider consulting pediatric infectious disease specialists regarding loading dose appropriateness.

Safety and Monitoring

Avoid concomitant nephrotoxic agents: Do not combine with other nephrotoxic or ototoxic drugs, including vancomycin and aminoglycosides 2.

Maximum daily limit: The total daily dose must not exceed 25,000 units/kg/day for children with normal renal function (340,000 units/day for this 13.6 kg child) 1.

Therapeutic drug monitoring: If available, TDM should be performed to optimize efficacy and minimize toxicity 2. Target steady-state AUC of 50–100 mg·h/L is recommended in adults; pediatric targets are less well-defined.

Common Pitfalls

  • Unit conversion errors: Polymyxin B sulfate uses 1 mg = 10,000 units. Pay careful attention to dosing units to avoid 10-fold errors 2
  • Inadequate initial dosing: Starting at the lower end of the range (15,000 units/kg/day) may result in subtherapeutic exposure for serious infections; consider 20,000–25,000 units/kg/day for severe infections
  • Failure to adjust for renal dysfunction: Even mild renal impairment requires dose reduction 1, 5
  • Storage: Solutions must be refrigerated and discarded after 72 hours 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.